nVerses Capital »

Theravance Biopharma shares owned by nVerses Capital

Quarter-by-quarter ownership of Theravance Biopharma (TBPH) shares owned by nVerses Capital from 13F filings

Historical chart of nVerses Capital investment in Theravance Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Theravance Biopharma held by nVerses Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Theravance Biopharma by nVerses Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $251k 15k 17.00

More positions owned by nVerses Capital

CenterPoint Energy (CNP)
Abbvie (ABBV)
Knight-swift Transn Hldgs In Cl A (KNX)
Wal-Mart Stores (WMT)
Target Corporation (TGT)
Peoples Ban (PEBO)
Delta Air Lines Com New (DAL)
Astrana Health Com New (ASTH)
SM Energy (SM)
American Superconductor Corp Shs New (AMSC)
Mirum Pharmaceuticals (MIRM)
Arthur J. Gallagher & Co. (AJG)
Wright Express (WEX)
Mosaic (MOS)
Marriott Vacations Wrldwde Cp (VAC)

View all positions for nVerses Capital

Top funds holding Theravance Biopharma

Madison Avenue Partners
Weiss Asset Management LP[1
BlackRock
Newtyn Management
Irenic Capital Management
Vanguard Capital Management
State Street Corporation
Two Sigma Investments
D. E. Shaw & Co
Acadian Asset Management
Geode Capital Management
Dimensional Fund Advisors
Mackenzie Financial
Oasis Management
Citadel Advisors

View all funds holding Theravance Biopharma